Effects of Fremanezumab on Psychiatric Comorbidities in Difficult-to-Treat Patients with Chronic Migraine: Post Hoc Analysis of a Prospective, Multicenter, Real-World Greek Registry

Objective: this post hoc analysis aimed to evaluate the efficacy of fremanezumab in difficult-to-treat chronic migraine (CM) patients with and without psychiatric comorbidities (PCs), mainly anxiety and/or depression. Methods: We assessed data from CM patients with and without PCs who failed at leas...

Descripción completa

Detalles Bibliográficos
Autores principales: Vikelis, Michail, Dermitzakis, Emmanouil V., Xiromerisiou, Georgia, Rallis, Dimitrios, Soldatos, Panagiotis, Litsardopoulos, Pantelis, Rikos, Dimitrios, Argyriou, Andreas A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10342907/
https://www.ncbi.nlm.nih.gov/pubmed/37445560
http://dx.doi.org/10.3390/jcm12134526

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10342907/
https://www.ncbi.nlm.nih.gov/pubmed/37445560
http://dx.doi.org/10.3390/jcm12134526

Ejemplares similares